PCP
UTHR icon

Proficio Capital Partners’s United Therapeutics UTHR Stock Holding History

Proficio Capital Partners’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-39
Closed -$3K – 1466
2019
Q2 		$3K Sell
39
-11
-22% -$1.03K ﹤0.01% 1447
2019
Q1 		$6K Sell
50
-4
-7% -$466 ﹤0.01% 1072
2018
Q4 		$6K Sell
54
-63
-54% -$7.3K ﹤0.01% 843
2018
Q3 		$15K Buy
117
+16
+16% +$1.98K ﹤0.01% 697
2018
Q2 		$11K Sell
101
-41
-29% -$4.51K ﹤0.01% 807
2018
Q1 		$16K Sell
142
-9
-6% -$1.14K ﹤0.01% 663
2017
Q4 		$22K Buy
151
+23
+18% +$2.92K 0.01% 562
2017
Q3 		$15K Sell
128
-34
-21% -$4.34K 0.01% 673
2017
Q2 		$21K Sell
162
-12
-7% -$1.5K 0.01% 602
2017
Q1 		$21K Buy
174
+64
+58% +$9.7K 0.01% 606
2016
Q4 		$16K Buy
110
+87
+378% +$11.1K 0.01% 512
2016
Q3 		$3K Hold
23
– – ﹤0.01% 828
2016
Q2 		$3K Buy
23
+3
+15% +$335 ﹤0.01% 793
2016
Q1 		$2K Buy
20
+6
+43% +$759 ﹤0.01% 793
2015
Q4 		$2K Buy
+14
New +$2.04K ﹤0.01% 695

Other funds holding UTHR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Proficio Capital Partners's UTHR Position: Q3 2019 in Review

Proficio Capital Partners sold out of United Therapeutics (UTHR) in Q3 2019, closing a stake of 39 shares — an estimated $3K sold.

Proficio Capital Partners first reported a position in UTHR in Q4 2015 and held it in 15 quarters. The position peaked at $22K in Q4 2017. 302 funds tracked by Wall St. Rank hold UTHR as of Q3 2019.

  • Proficio Capital Partners reported no remaining United Therapeutics position as of Q3 2019 after selling out during the quarter.
  • Proficio Capital Partners sold 39 United Therapeutics shares in Q3 2019, an estimated $3K.
  • Proficio Capital Partners first reported a position in United Therapeutics in Q4 2015 and held it in 15 quarters.
  • Proficio Capital Partners's United Therapeutics position peaked at $22K in Q4 2017.
  • 302 funds tracked by Wall St. Rank held United Therapeutics as of Q3 2019.

Based on Proficio Capital Partners's 13F filing for Q3 2019, filed 13 Nov 2019.